quinazolines has been researched along with Bone Loss, Perimenopausal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, J; Wu, JC; Xu, JC; Zhang, YF; Zhou, ZY | 1 |
| Hofbauer, LC; Khosla, S; Rachner, TD | 1 |
1 review(s) available for quinazolines and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Osteoporosis: now and the future.
Topics: Absorptiometry, Photon; Adaptor Proteins, Signal Transducing; Aged; Aged, 80 and over; Anabolic Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzodioxoles; Biphenyl Compounds; Bone Density; Bone Density Conservation Agents; Bone Morphogenetic Proteins; Bone Remodeling; Bone Resorption; Calcium; Denosumab; Diphosphonates; Female; Genetic Markers; Humans; Intercellular Signaling Peptides and Proteins; Middle Aged; Osteoblasts; Osteoclasts; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Quinazolines; Randomized Controlled Trials as Topic; RANK Ligand; Risk Assessment; Risk Factors; Vitamin D Deficiency; Wnt Proteins | 2011 |
1 other study(ies) available for quinazolines and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Down-regulated microRNA-199a-3p enhances osteogenic differentiation of bone marrow mesenchymal stem cells by targeting Kdm3a in ovariectomized rats.
Topics: Animals; Antigens, CD; Azepines; Bone and Bones; Disease Models, Animal; Down-Regulation; Female; Gene Expression Regulation; Gene Knockdown Techniques; Gene Regulatory Networks; Genes, Reporter; Histone Demethylases; Humans; Kruppel-Like Transcription Factors; Mesenchymal Stem Cells; MicroRNAs; Mitogen-Activated Protein Kinase 1; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Ovariectomy; Quinazolines; Rats; Rats, Sprague-Dawley | 2021 |